×
Customize
?
Start
Cancer Types
Quick Links
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Side effects decreased among patients with high-risk ovarian cancer who received an individualized starting dose of Zejula (niraparib), based upon baseline bodyweight and platelet counts, compared with a fixed starting dose.
Kristie L. Kahl
Patients with recurrent ovarian cancer who received Zejula (niraparib) maintenance therapy experienced more time without symptoms or toxicity compared with placebo, according to results from the phase 3 ENGOT-OV16/NOVA trial.
Katie Kosko and Jessica Skarzynski
The importance of teamwork between patients and their care teams and caregivers was a common theme at the second annual Ovarian Cancer Heroes event held in Honolulu, Hawaii.
More
Voices
Kathy LaTour
Of all the things that cancer left me with, scarred veins in my only good arm has been the worst. I have learned to treasure those techs who can find a good vein and hit it the first time.
Diana M. Martin
A caregiver's view on why this bill needs careful consideration.
Sarah DeBord
One is meant to improve quality of life and the other is meant to care for end-of-life. Yet the two specialties of palliative and hospice care still continue to be confused not only by the patient, but also the provider.
More
CURE Connections®
Meryl Kaufman, M.Ed., CCC-SLP, BRS-S, and Itzhak Brook, M.D., M.Sc., board members of the Head and Neck Cancer Alliance, provide their perspectives on adjusting to life with cancer of the head and neck, as a patient or as a caregiver, and share advice for those who must undergo laryngectomy.
Meryl Kaufman, M.Ed., CCC-SLP, BRS-S, and Itzhak Brook, M.D., M.Sc., board members of the Head and Neck Cancer Alliance, share insight into the role of novel treatment approaches like immunotherapy, robotic surgery and de-escalation in the management of cancers of the head and neck.
Meryl Kaufman, M.Ed., CCC-SLP, BRS-S, and Itzhak Brook, M.D., M.Sc., board members of the Head and Neck Cancer Alliance, review the various modalities of treatment for cancers of the head and neck and identify which physicians are responsible for delivering this care.
More
Videos
Alexandra Guadagno
An expert discusses the future of immunotherapy in light of new frontline treatments like Keytruda that have been demonstrating positive results for patients with non–muscle invasive bladder cancer.
Mark Socinski, M.D.
Thanks to better understanding of cancer biology, the outlook for advanced lung cancer is better than it has ever been.
Jean Diesch
Any action, larger or small, can make a major impact in the lives of patients with a myeloproliferative neoplasm.
More
Podcasts
Kristie L. Kahl
In this week’s episode, we spoke with Linda Tantawi about Susan G. Komen Greater New York City, and how the organization is connecting communities to educate women about breast cancer.
Kristie L. Kahl
In this week’s episode, we spoke with a patient advocate and survivor of renal cell carcinoma to help raise awareness during Kidney Cancer Awareness month.
Kristie L. Kahl
In this week’s episode, we spoke with actor Scott Foley, who opened up about his experience as a caregiver to his mother after her ovarian cancer diagnosis and why he joined the Not on My Watch movement to help educate others.
More
